Literature DB >> 16912885

On the effects of apomorphine in mammals and frogs.

Klaus Kuschinsky1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912885     DOI: 10.1007/s00210-006-0089-7

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  12 in total

Review 1.  Actions of narcotics on brain dopamine metabolism and their relevance for "psychomotor" effects.

Authors:  K Kuschinsky
Journal:  Arzneimittelforschung       Date:  1976-04

2.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

Authors:  A CARLSSON; M LINDQVIST
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

3.  Metabolism and storage of biogenic amines.

Authors:  H BLASCHKO
Journal:  Experientia       Date:  1957-01-15

4.  Evidence for dopamine receptor stimulation by apomorphine.

Authors:  N E Andén; A Rubenson; K Fuxe; T Hökfelt
Journal:  J Pharm Pharmacol       Date:  1967-09       Impact factor: 3.765

5.  [Therapy of withdrawal symptoms in "fixers". (Drug abuse of adolescents by intravenous injection)].

Authors:  M Amitai; H H Dickhaut; P Hasenknopf
Journal:  Nervenarzt       Date:  1972-03       Impact factor: 1.214

6.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

7.  Effect of dopamine D3 receptor blockade on renal function and glomerular size in diabetic rats.

Authors:  Gerd Luippold; Martina Beilharz; Manfred Wehrmann; Liliane Unger; Gerhard Gross; Bernd Mühlbauer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-05-11       Impact factor: 3.000

8.  Prospective, randomized, crossover comparison of sublingual apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunction.

Authors:  C Pavone; F Curto; G Anello; V Serretta; P L Almasio; M Pavone-Macaluso
Journal:  J Urol       Date:  2004-12       Impact factor: 7.450

9.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1961-11-10       Impact factor: 1.704

10.  [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Authors:  H EHRINGER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1960-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.